CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer

Jaewoon Jeong, Jae Baek Ha, In Ho Chang

Korean J Urol Oncol. 2022;20(1):12-24. Published online 2022 February 24 DOI: https://doi.org/10.22465/kjuo.2022.20.1.12

New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer

Jaewoon Jeong, Jae Baek Ha, In Ho Chang

The Korean Journal of Urological Oncology. 2022;20(1):12-24

Link1

Link2 Link3

Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer

Hyung Suk Kim, Ho Kyung Seo

Investigative and Clinical Urology. 2021;62:

Link1 Link2 Link3

Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease

Ryan L. Steinberg, Lewis J. Thomas, Michael A. O’Donnell

Bladder Cancer. 2015;1(2):105-116

Link1

Editorial comment on “Maintenance bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials”

Shu-Pin Huang

Urological Science. 2015;26(2):101-102

Link1 Link2

Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer

Marc Decobert, Hélène LaRue, François Harel, François Meyer, Yves Fradet, Louis Lacombe

Cancer. 2008;113(4):710-716

Link1 Link2

Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease

Ryan L. Steinberg, Lewis J. Thomas, Sarah L. Mott, Michael A. O’Donnell

Bladder Cancer. 2016;2(2):215-224

Link1

The Challenge of Bacillus Calmette-Guérin Failure in Nonmuscle Invasive Bladder Cancer—What is the Next Step in Management?

Yair Lotan

Journal of Urology. 2013;190(3):832-833

Link1 Link2 Link3

Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guérin Downregulation of Nonmuscle-invasive Bladder Cancer

Juliana A. Camargo, Gabriela R. Passos, Karen L. Ferrari, Athanase Billis, Mário J.A. Saad, Leonardo O. Reis

Clinical Genitourinary Cancer. 2018;16(3):e587-e593

Link1 Link2

Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle invasive Bladder Cancer: Con

Elisabeth Grobet-Jeandin, Ugo Pinar, Morgan Rouprêt

European Urology Focus. 2021;

Link1 Link2

Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guérin Treatment

Andrew T. Lenis, Kian Asanad, Maher Blaibel, Nicholas M. Donin, Karim Chamie

Urology Practice. 2018;5(2):132-138

Link1 Link2 Link3